相关实验视频
Updated: May 21, 2025

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
在HR修复过程中,TAOK1通过酸化USP7促进了线材的形成
Tian-Chen Zhu1,2, Zhang-Ping He3, Shu-Ting Li1,2
1State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou 510000, China.
一千和一个氨基酸蛋白激酶1 (TAOK1) 抑制增强了PARP抑制剂在癌症中的有效性. 阻断TAOK1或其与USP7的相互作用会降解RAD51,破坏DNA修复并增加癌细胞对PARP抑制剂的敏感性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 聚ADP-ribose聚合酶 (PARP) 抑制剂是同源重组 (HR) 缺陷的瘤的关键癌症疗法.
- 扩大PARP抑制剂的临床使用受到抵抗机制的限制.
研究的目的:
- 通过PARP抑制剂确定合成致死性的新目标.
- 调查千和一个氨基酸蛋白激酶1 (TAOK1) 在DNA损伤反应和PARP抑制剂耐药性的作用.
主要方法:
- 高通量激酶抑制剂选,以找到与PARP抑制剂合成致命的标.
- 基因耗尽和TAOK1.1的药理抑制.
- 对RAD51稳定性和HR修复功能的评估.
- 对癌细胞对PARP抑制的敏感性的评估.
主要成果:
- TAOK1酸化了全域基因特异性酶7 (USP7),增强了它的活性.
- USP7活动防止RAD51的无处不在和降解,保持HR修复.
- 抑制TAOK1或USP7功能会导致RAD51降解和HR修复缺陷.
- 抑制TAOK1或阻断USP7的可以增加癌细胞对PARP抑制剂的敏感性.
结论:
- TAOK1是人类癌细胞中HR修复途径的关键调节者.
- 将PARP抑制剂与TAOK1抑制或USP7向酸相结合,提供了一种克服PARPi耐药性的策略.
- 这种方法有可能改善癌症治疗的治疗结果.
更多相关视频
10:44Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
Published on: January 31, 2018
12:19Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
Published on: November 10, 2016
相关概念视频
Restarting Stalled Replication Forks
DNA Damage can Stall the Cell Cycle
Homologous Recombination
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Generation of Straight or Branched Actin Filaments
Arp2/3 Complex
Arp2/3 complex is a seven-subunit complex consisting of two proteins similar to actin- Arp2 and Arp3, and five other subunits that help keep Arp2 and Arp3 inactive. When required, the complex is...